Suchergebnisse - "Lasky, Joseph A"

PubPharm (173)

1

Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials : Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency

enthalten in: American journal of respiratory and critical care medicine | 2024

von Raghu, G. | Ghazipura, M. | Fleming, T. | +35

2

Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases

enthalten in: Thorax | 2024

von Kawano-Dourado, L. | Kulkarni, T. | Ryerson, C. | +129

3

Mycophenolate and azathioprine efficacy in interstitial lung disease : a systematic review and meta-analysis

enthalten in: BMJ open respiratory research | 2024

von Lombardi, F. | Stewart, I. | Fabbri, L. | +105

4

Enhanced Expression of a Novel Lamin A/C Splice Variant in Idiopathic Pulmonary Fibrosis Lung

enthalten in: American journal of respiratory cell and molecular biology | 2023

von Yin, Q. | Morris, G. | Saito, S. | +4

5

Interstitial lung disease progression after genomic usual interstitial pneumonia testing

enthalten in: The European respiratory journal | 2023

von Chaudhary, S. | Weigt, S. | Ribeiro Neto, M. | +11

CommentIn: Eur Respir J. 2023 Apr 1;61(4):. - PMID 37003611

6

NOTCH-ing up Surface Tension in the Fibrotic Lung

enthalten in: American journal of respiratory and critical care medicine | 2023

von Lasky, J. | Thannickal, V.

CommentOn: Am J Respir Crit Care Med. 2023 Feb 1;207(3):283-299. - PMID 36047984

7

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease : a randomised, double-blind, placebo-controlled, phase 2 study

enthalten in: The Lancet. Respiratory medicine | 2023

von Solomon, J. | Danoff, S. | Woodhead, F. | +105

CommentIn: Lancet Respir Med. 2023 Jan;11(1):8-9. - PMID 36075241

8

Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

enthalten in: BMC pulmonary medicine | 2022

von Podolanczuk, A. | Kim, J. | Cooper, C. | +74

9

Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

enthalten in: BMC pulmonary medicine | 2022

von Podolanczuk, A. | Kim, J. | Cooper, C. | +8

10

Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

enthalten in: BMC pulmonary medicine | 2022

von Podolanczuk, A. | Kim, J. | Cooper, C. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]